Sort
59,101 grants matching “hypertension”
Activation of the Angiopoietin-Tie2 Pathway to Treat Ocular Hypertension and Glaucoma
$695,357Susan E Quaggin · Northwestern University At Chicago · R01 · FY2019 · EY
Activation of the Angiopoietin-Tie2 Pathway to Treat Ocular Hypertension and Glaucoma
$695,357Susan E Quaggin · Northwestern University At Chicago · R01 · FY2017 · EY
Comprehensive Cardiac Structure-Function Analysis in Heart Transplantation
$695,340Michael Markl · Northwestern University At Chicago · R01 · FY2021 · HL
Deep South Partnership for Prevention of CVD Disparities
$695,299James Shikany · University Of Alabama At Birmingham · U01 · FY2008 · HL
Assessing a Medicaid Randomized Insurance Experiment within Community Clinics
$695,287Jennifer E Devoe · Oregon Health & Science University · R01 · FY2012 · HL
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
$695,285Alexander Egbe · Mayo Clinic Rochester · R01 · FY2023 · HL
iSIPsmarter: An RCT to evaluate the efficacy, reach, and engagement of a technology-based behavioral and health literacy intervention to reduce sugary beverages among rural Appalachian adults
$695,270Jamie Zoellner · University Of Virginia · R01 · FY2020 · MD
Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetes
$695,237Ming C Gong · University Of Kentucky · R01 · FY2023 · HL
Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetes
$695,237Ming C Gong · University Of Kentucky · R01 · FY2025 · HL
Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetes
$695,237Ming C Gong · University Of Kentucky · R01 · FY2022 · HL
Early phase clinical trials of 211At-meta-astatobenzylguanidine for children with neuroblastoma and adults with advanced neuroendocrine cancers
$695,205Vivek Narayan · University Of Pennsylvania · R01 · FY2025 · CA
CARDIA-PLUS: A Life Course Investigation of Biopsychosocial Pathways to Bladder Health and Lower Urinary Tract Symptoms
$695,177Sonya S Brady · University Of Minnesota · R01 · FY2021 · DK
Taxi Health Access Interventions for Linkages and Lifestyle (HAILL)
$695,124Francesca M Gany · Sloan-Kettering Inst Can Research · R01 · FY2018 · NR
Experimental Pathology of Cardiovascular Disease
$695,109University Of Washington · T32 · FY2004 · HL
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$695,031William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
The role of irregular sleep schedules as a ubiquitous marker of chronic circadian disruption in cardiometabolic disease development
$695,016Tianyi Huang · Brigham And Women'S Hospital · R01 · FY2022 · HL
CommunityRx â Chronic Kidney Disease (CRx-CKD)â An EMR-integrated community resources referral intervention to address structural racism and kidney health disparities in rural North Carolina
$694,999Gaurav J Dave · Univ Of North Carolina Chapel Hill · U01 · FY2024 · DK
Anti-Inflammatory Lipid Mediators in Asthma
$694,959Bruce A Freeman · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · HL
Primary Aldosteronism Subtypes: Pathophysiology and Steroid Signatures
$694,942Adina F Turcu · University Of Michigan At Ann Arbor · R01 · FY2023 · HL
Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations
$694,908Nadia S Islam · New York University School Of Medicine · R01 · FY2025 · MD
Estrogen signaling in portopulmonary hypertension
$694,908Steven M Kawut · University Of Pennsylvania · R01 · FY2013 · HL
Urate as a Predictor of Parkinson's Disease Risk and Progression
$694,904Alberto Ascherio · Harvard School Of Public Health · R01 · FY2012 · NS
Improving Medication Adherence among Underserved Patients with Type 2 Diabetes
$694,903Lindsay S. Mayberry · Vanderbilt University Medical Center · R01 · FY2016 · DK
Letrozole for Treatment of Uterine Fibroids: A randomized, placebo-controlled trial
$694,900Vanessa Jacoby · University Of California, San Francisco · R01 · FY2023 · HD
Multilevel mobile health program to improve rural hypertension
$694,845Jared W. Magnani · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL